Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 known ✓ | P22748 | 2/20 | 0.41 |
| ▸ | CA2 known ✓ | P00918 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tricarballylic Acid SCHEMBL4898296 | 0.82 | CA4 (0.57) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL29165746 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL30504723 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL11318639 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL8979864 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL6757050 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL8329650 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL11318645 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL28977121 | 0.77 | CA4 (0.52) | CA4CA2CYP3A4TSHRNFKB1 | |
| Tricarballylic Acid SCHEMBL6551788 | 0.73 | CA4 (0.48) | CA4CA2CYP3A4TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037542-B2 | Method of using multicarboxylate compositions in enhanced oil recovery | CHEVRON U.S.A. INC. | 2024-07-16 | — | — | US | disclosed |
| US-20220162499-A1 | METHOD OF USING MULTICARBOXYLATE COMPOSITIONS IN ENHANCED OIL RECOVERY | CHEVRON U.S.A. INC. | 2022-05-26 | — | — | US | disclosed |
| US-11248159-B2 | Method of using multicarboxylate compositions in enhanced oil recovery | CHEVRON U.S.A. INC. (US) | 2022-02-15 | — | — | US | disclosed |
| US-20190153299-A1 | METHOD OF USING MULTICARBOXYLATE COMPOSITIONS IN ENHANCED OIL RECOVERY | CHEVRON U.S.A. INC. | 2019-05-23 | — | — | US | disclosed |
| US-10233382-B2 | Method of using multicarboxylate compositions in enhanced oil recovery | CHEVRON U.S.A. INC. (US) | 2019-03-19 | — | — | US | disclosed |
| US-9976072-B2 | Multicarboxylate compositions and method of making the same | CHEVRON U.S.A. INC. (US) | 2018-05-22 | — | — | US | disclosed |
| EP-2924093-B1 | MULTICARBOXYLATE COMPOSITIONS AND METHOD OF MAKING THE SAME | CHEVRON USA INC (US) | 2017-11-29 | — | — | EP | disclosed |
| US-20170198202-A1 | METHOD OF USING MULTICARBOXYLATE COMPOSITIONS IN ENHANCED OIL RECOVERY | CHEVRON U.S.A. INC. | 2017-07-13 | — | — | US | disclosed |
| US-20150275068-A1 | Multicarboxylate Compositions And Method Of Making The Same | CHEVRON U.S.A. INC. | 2015-10-01 | — | — | US | disclosed |
| EP-2924093-A1 | MULTICARBOXYLATE COMPOSITIONS AND METHOD OF MAKING THE SAME | Chevron U.S.A., Inc. (US) | 2015-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11248159-B2 | Method of using multicarboxylate compositions in enhanced oil recovery | SCO2, ELOVL3, PCCA | CA4 2218/4885CA2 561/4885CYP3A4 2062/4885 |
| US-10233382-B2 | Method of using multicarboxylate compositions in enhanced oil recovery | SCO2, PCCA, SLC25A20 | CA4 1142/4885CA2 146/4885CYP3A4 2068/4885 |
| US-20150275068-A1 | Multicarboxylate Compositions And Method Of Making The Same | ALKBH3, C9, SLC25A20 | CA4 926/4885CA2 59/4885CYP3A4 2138/4885 |
| US-20220162499-A1 | METHOD OF USING MULTICARBOXYLATE COMPOSITIONS IN ENHANCED OIL RECOVERY | SCO2, ELOVL3, PCCA | CA4 2040/4885CA2 463/4885CYP3A4 2005/4885 |
| US-12037542-B2 | Method of using multicarboxylate compositions in enhanced oil recovery | SCO2, ELOVL3, PCCA | CA4 2040/4885CA2 463/4885CYP3A4 2005/4885 |
| US-20190153299-A1 | METHOD OF USING MULTICARBOXYLATE COMPOSITIONS IN ENHANCED OIL RECOVERY | SCO2, ELOVL3, PCCA | CA4 2218/4885CA2 561/4885CYP3A4 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.